(S)-2-(1-oxoisoindolin-2-yl)propanoic acid | 180923-78-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (S)-2-(1-oxoisoindolin-2-yl)propanoic acid
• 英文别名: (2S)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionic acid；(2S)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)propanoic acid；(2S)-2-(3-oxo-1H-isoindol-2-yl)propanoic acid
• CAS: 180923-78-8
• 化学式: C₁₁H₁₁NO₃
• mdl: MFCD10007657
• 分子量: 205.213
• InChiKey: XBPWPQBDGZFHQI-ZETCQYMHSA-N

物化性质

• 沸点：
  431.5±45.0 °C(Predicted)
• 密度：
  1.342±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.272
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (S)-2-(1-oxoisoindolin-2-yl)propanoic acid 在 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 sodium hydroxide 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.5h， 生成 (2S,4R)-N-((1H-indol-3-yl)methyl)-4-hydroxy-1-((S)-2-(1-oxoisoindolin-2-yl)propanoyl)pyrrolidine-2-carboxamide
  参考文献：
  名称：

  Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

  摘要：

  本发明涉及双功能化合物，其作为靶向泛素化的调节剂具有实用性，特别是作为本发明的双功能化合物对各种被降解和/或受到抑制的多肽和其他蛋白质的抑制剂。具体而言，本发明涉及含有一端结合泛素连接酶的VHL配体，另一端结合靶蛋白的基团的化合物，使得靶蛋白靠近泛素连接酶以促使该蛋白的降解（和抑制）。本发明展示了与本发明化合物相关的广泛的药理活性范围，与靶向多肽的降解/抑制一致。

  公开号：

  US20140356322A1
• 作为产物：
  描述：

  (2S)-2-[1-(2-hydroxyethylsulfanyl)isoindol-2-yl]propanoic acid 生成 (S)-2-(1-oxoisoindolin-2-yl)propanoic acid
  参考文献：
  名称：

  FRISTER, H.;MEISEL, H.;SCHLIMME, E., FRESENIUS Z. ANAL. CHEM., 330,(1988) N 7, 631-633

  摘要：

  DOI：

文献信息

• Conversion of <i>N</i>-Acyl Amino Acids into Imides via Oxidative Decarboxylation Induced by Ag⁺/Cu²⁺/S₂O₈^2- in Water
  作者：Wenhua Huang、Meiling Wang、Hong Yue

  DOI：10.1055/s-2008-1072563

  日期：2008.5

  N-Acyl amino acids can be converted by oxidative decarboxylation induced by Ag + /Cu 2+ /S 2 O 8 2- at room temperature in water into imides in 24-89% yields. Both N-benzoylvaline and N-benzoylleucine gave N-formylbenzamide, which possibly results from oxidative cleavage of an enamide intermediate.

  N-酰基氨基酸可以在室温下通过 Ag + /Cu 2+ /S 2 O 8 2- 诱导的氧化脱羧在水中转化为酰亚胺，产率为 24-89%。N-苯甲酰缬氨酸和 N-苯甲酰亮氨酸都产生 N-甲酰苯甲酰胺，这可能是由烯酰胺中间体的氧化裂解产生的。
• ESTROGEN-RELATED RECEPTOR ALPHA BASED PROTAC COMPOUNDS AND ASSOCIATED METHODS OF USE
  申请人：Yale University

  公开号：US20160045607A1

  公开（公告）日：2016-02-18

  The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.

  本发明涉及双功能化合物，其作为靶向泛素化的调节剂具有实用性，特别是根据本发明抑制各种多肽和其他蛋白质的抑制剂。具体而言，本发明涉及一种在一端含有结合泛素连接酶的VHL配体，另一端含有结合靶蛋白的基团的化合物，使得靶蛋白位于靠近泛素连接酶以实现对该蛋白的降解（和抑制）。本发明展示了与根据本发明的化合物相关的广泛的药理活性范围，与靶向多肽的降解/抑制一致。
• Caspase inhibitors and uses thereof
  申请人：——

  公开号：US20030232846A1

  公开（公告）日：2003-12-18

  This invention provides novel compounds, and pharmaceutically acceptable derivatives thereof, that are useful as caspase inhibitors. These compounds have the general formula I: 1 where R 1 , R 2 , and R 3 are as described herein, Ring A contains zero to two double bonds, each X is independently selected from nitrogen or carbon, at least one X in Ring A is a nitrogen, Ring A is optionally substituted as described, and may be fused to a saturated or unsaturated five to seven membered ring containing zero to three heteroatoms, and provided that when X 3 is a carbon, a substituent on X 3 is attached by an atom other than nitrogen.

  这项发明提供了新颖的化合物及其药用可接受的衍生物，其作为caspase抑制剂有用。这些化合物具有一般式I：其中R1、R2和R3如本文所述，环A含有零至两个双键，每个X独立地选自氮或碳，环A中至少一个X是氮，环A如所述可被取代，且可与含有零至三个杂原子的饱和或不饱和的五至七元环融合，且当X3为碳时，X3上的取代基由非氮原子连接。
• CASPASE INHIBITORS AND USES THEREOF
  申请人：Golec Julian M.C.

  公开号：US20120077830A1

  公开（公告）日：2012-03-29

  This invention provides novel compounds, and pharmaceutically acceptable derivatives thereof, that are useful as caspase inhibitors. These compounds have the general formula I: where R 1 , R 2 , and R 3 are as described herein, Ring A contains zero to two double bonds, each X is independently selected from nitrogen or carbon, at least one X in Ring A is a nitrogen, Ring A is optionally substituted as described, and may be fused to a saturated or unsaturated five to seven membered ring containing zero to three heteroatoms, and provided that when X 3 is a carbon, a substituent on X 3 is attached by an atom other than nitrogen.

  本发明提供了新型化合物及其药学上可接受的衍生物，它们可用作caspase抑制剂。这些化合物的一般式为I：其中R1、R2和R3如本文所述，环A含零至两个双键，每个X独立地选自氮或碳，环A中至少有一个X为氮，环A可按所述进行取代，并且可以与含零至三个杂原子的饱和或不饱和的五至七元环融合，且在X3为碳时，X3上的取代基由非氮原子连接。
• COMPOUNDS & METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS & OTHER POLYPEPTIDES BY AN E3 UBIQUITIN LIGASE
  申请人：Yale University

  公开号：EP3608317A1

  公开（公告）日：2020-02-12

  The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.

  本发明涉及双功能化合物，它们可作为靶向泛素化的调节剂，特别是可被根据本发明的双功能化合物降解和/或以其他方式抑制的各种多肽和其他蛋白质。特别是，本发明涉及的化合物一端含有与泛素连接酶结合的 VHL 配体，另一端含有与靶蛋白结合的分子，从而使靶蛋白靠近泛素连接酶，以实现对该蛋白的降解（和抑制）。本发明显示了与根据本发明的化合物相关的广泛的药理活性，与降解/抑制靶向多肽一致。